![Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914919306034-gr1.jpg)
Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![Table-2.-The-2009-Birmingham-Scheme-–-CHA2DS2-VASc-Scoring-System-240x300 - The British Journal of Cardiology Table-2.-The-2009-Birmingham-Scheme-–-CHA2DS2-VASc-Scoring-System-240x300 - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2015/09/Table-2.-The-2009-Birmingham-Scheme-%E2%80%93-CHA2DS2-VASc-Scoring-System-240x300.png)
Table-2.-The-2009-Birmingham-Scheme-–-CHA2DS2-VASc-Scoring-System-240x300 - The British Journal of Cardiology
![CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country](https://ctlin.blog/wp-content/uploads/2019/01/cha2ds2vaschasbled-e1547658221355.png)
CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country
![Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//18855857/0000006700000005/v2_201404301330/S1885585714000875/v1_201404301330/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1NQLWG100M7OZEJTign/qk7QbeYCCyuw6a6ycScaDlM3ve8r65UmLCvkPhK/i4zLvWaU8d+isV8nmswilE8vNx1fduE/DZDFuPgpHvaqELtL2CId+ktKY7IQ6b9XOKxfMkNZ/LlQc6NISuFwY5IJr7Ka4t612lDxCCJ84r9JhsKiXkZ2NMumzZNfiFcTjwG32kzVEmMiGwQHIZ75r/Ciw+FkZyaS7tMRpsE38PC8DJdEQ=)
Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología
![Table 1 from Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score. | Semantic Scholar Table 1 from Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f305230d872cf1bb0b0e03804b2b127b2e47b1ee/2-Table1-1.png)
Table 1 from Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score. | Semantic Scholar
![Table 3 from Use of CHA2DS2-VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study. | Semantic Scholar Table 3 from Use of CHA2DS2-VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1cfc09b8139144dbe3a3b3a90142d28b6f4d0ab4/4-Table3-1.png)
Table 3 from Use of CHA2DS2-VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study. | Semantic Scholar
CorConsult Rx - Here is a summary of CHADS VASc score to evaluate a patient's risk of forming an embolism (leading to a stroke) secondary to their atrial fibrillation. If you answer
![Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109714073914-gr2.jpg)
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect
![Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/3-Table2-1.png)
Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![PDF] Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study | Semantic Scholar PDF] Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6c1fd0f9e7bac50313111abea78d3abee4082af2/3-Table1-1.png)